Previous Article | Next Article ![]()
Journal of Virology, October 2000, p. 9479-9487, Vol. 74, No. 20
Departments of
Pathology1 and Molecular Biology and
Microbiology,4 Graduate Program in
Immunology,3 and Medical Scientist
Training Program,2 Tufts University School of
Medicine, Boston, Massachusetts 02111
Received 2 February 2000/Accepted 17 July 2000
In many tumor systems, analysis of cells for loss of heterozygosity
(LOH) has helped to clarify the role of tumor suppressor genes in
oncogenesis. Two important tumor suppressor genes, p53 and
the Ink4a/Arf locus, play central roles in the multistep
process of Abelson murine leukemia virus (Ab-MLV) transformation. p53 and the p53 regulatory protein, p19Arf, are required for the apoptotic crisis that characterizes the progression of primary transformed pre-B
cells to fully malignant cell lines. To search for other tumor
suppressor genes which may be involved in the Ab-MLV transformation process, we used endogenous proviral markers and simple-sequence length
polymorphism analysis to screen Abelson virus-transformed pre-B cells
for evidence of LOH. Our survey reinforces the role of the p53-p19
regulatory pathway in transformation; 6 of 58 cell lines tested had
lost sequences on mouse chromosome 4, including the
Ink4a/Arf locus. Consistent with this pattern, a high
frequency of primary pre-B-cell transformants derived from
Ink4a/Arf +/
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Loss of Heterozygosity at the Ink4a/Arf
Locus Facilitates Abelson Virus Transformation of Pre-B Cells

and
mice became established cell lines. In
addition, half of them retained the single copy of the locus when the
transformation process was complete. These data demonstrate that a
single copy of the Ink4a/Arf locus is not sufficient to
fully mediate the effects of these genes on transformation.
*
Corresponding author. Mailing address: SC315, Tufts
University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-2143. Fax: (617) 636-0337. E-mail:
nrosenbe{at}opal.tufts.edu.
Present address: Department of Microbiology, Columbia University
College of Physicians and Surgeons, New York, NY 10032.
Present address: Department of Pathology, Brigham and Women's
Hospital, Boston, MA 02115.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|